Pre-Transplantation MRD Status Predicts Survival in Acute Leukemia
Researchers sought to determine whether MRD status could be a helpful prognostic tool for survival in patients with acute leukemia prior to allo-HSCT.
Hematopoietic Stem Cell Transplantation
Decitabine Improved Outcomes for Patients With Refractory Prolonged Isolated Thrombocytopenia
Researchers sought to determine whether decitabine could improve platelet counts and survival rates in patients with RPIT.
Next-Generation Sequencing May Help Identify Infection in Hematologic Malignancies
Researchers reviewed patient samples to determine whether NGS of cell-free DNA may help in treatment decision-making for patients with hematologic malignancies who may have an infection.
Haplo-Identical Donors as an Alternative for Patients With Fanconi Anemia
Researchers sought to determine whether haplo-identical donors could be an alternative option for patients with Fanconi anemia undergoing HSCT.
Factors Associated With Mortality Following COVID-19 in Recipients of Hematopoietic Cell Transplant
Researchers have identified various factors associated with mortality following a diagnosis with the COVID-19 virus among recipients of allogeneic and autologous HCT.
Lower Gastrointestinal, Not Upper GI Graft-Versus-Host Disease Increases Healthcare Utilization and Economic Burden for Patients
Researchers have sought to determine the monetary cost of specific aGVHD staging and organ involvement for patients who receive HSCT, a topic which remains poorly understood.
Haplo-Identical Donors as an Alternative for Patients With Fanconi Anemia
Researchers sought to determine whether haplo-identical donors could be an alternative option for patients with Fanconi anemia undergoing HSCT.
TBI Conditioning Before Stem Cell Transplantation Improves Survival in Pediatric ALL
Researchers sought to determine whether pediatric patients with ALL would have better OS if they received TBI prior to HSCT.
Older Patients With MDS Have Survival Benefit From Transplantation
Researchers assessed if older patients with high-risk myelodysplastic syndrome experience significant overall survival benefit from hematopoietic transplantation.
Factors Associated With Mortality Following COVID-19 in Recipients of Hematopoietic Cell Transplant
Researchers have identified various factors associated with mortality following a diagnosis with the COVID-19 virus among recipients of allogeneic and autologous HCT.
-
Loading...
-
Loading...
Next post in General Hematology
